2023 CBIIC in Suzhou Industrial Park on September 25-27, 2023.
Associate Director of Warburg Pincus
Associate Director, WARBURG PINCUS Mr. Du is the Associate Director at WARBURG PINCUS, focusing on China healthcare research and investments. Prior to joining WARBURG PINCUS, Mr. Du worked as Portfolio Manager, Lead Analyst of Healthcare Strategic Investments at PINGAN LIFE INSURANCE (601318.SH/2318.HK); and Chief Strategy Officer, Vice President at SANPOWER GROUP. Also, Mr. Du worked as the Head of China Healthcare Research, Chief Healthcare Equity Research Analyst at SHENWAN HONGYUAN SECURITIES (000166.SZ/6806.HK), covering leading healthcare and pharmaceutical companies in A-Share and A+H Share stock market in China, with extensive research experience and industry resources in China healthcare sector. He ranked No.1 in Crystal Ball Awards (China Sell-Side Analysts Survey). Mr. Du also worked in investment banking and management consulting industry in China, as well as biomedicine R&D in the United States. He holds a MBA degree from University of Michigan Ross School of Business, and a M.S. degree in Biomedicine from University of Michigan, Ann Arbor